I work with children and their families to form personalized care plans. Parents are the experts on their own child, and I want to help them take care of their child's lungs.
Elizabeth L. Kramer, MD, PhD

About

Biography

I love working with children — they are resilient, funny and brave. It's my goal to help children breathe well so they can live the life they want.

As a pediatric pulmonologist, I specialize in taking care of children with lung disease, including those with asthma, chronic cough, recurrent pneumonia and cystic fibrosis. I am a member of the Cystic Fibrosis Center at Cincinnati Children’s.

I work with children and their families to form personalized care plans. Parents are the experts on their own child, and I want to help them take care of their child's lungs.

In my research, I am interested in why cystic fibrosis lung disease severity is so variable from person to person. I am studying a chemical made in the body, called TGFbeta, which might worsen lung disease in certain people. Studying this chemical may help us discover new therapies to stop early lung damage in cystic fibrosis.

I am a recipient of the Procter Scholar Award, which supports highly promising junior faculty pursuing a career in academic research. My research has been supported by funding from the Cystic Fibrosis Foundation and Cystic Fibrosis Research, Inc.

When I’m not at work, I enjoy spending time with my husband and two daughters. We have lived in Cincinnati more than 15 years.

PhD: University of Cincinnati, Cincinnati, OH, 2009.

MD: University of Cincinnati, Cincinnati, OH, 2011.

Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2014.

Fellowship: Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2016.

Certification: Pediatrics, 2014.

Services and Specialties

Research Areas

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Hypercubes to identify geomarkers of rapid cystic fibrosis lung disease progression. Cheng, Y; Brokamp, C; Manning, ER; Kramer, EL; Ryan, PH; Szczesniak, RD; Gecili, E. BMC Medical Informatics and Decision Making. 2025; 25:304.

710 Near-road air pollution inhibits long-term modulator effectiveness. Darkwah, O; Colegate, S; Brokamp, C; Ryan, P; Manning, E; Gecili, E; Brewington, J; Kramer, E; Szczesniak, R. Journal of Cystic Fibrosis. 2025; 24:s425-s426.

88 Neutrophil extracellular traps increase human bronchial epithelial iron release and promote Pseudomonas aeruginosa growth. Dasgupta, A; Imbrogno, M; Pasula, R; Middleton, R; Baird, D; Kramer, E; Brewington, J; Morgan, H; Meeker, J; Mahajan, S; Wozniak, D; Gardner, J; Trapnell, B; Clancy, J; Hudock, K. Journal of Cystic Fibrosis. 2025; 24:s45-s46.

Optimizing Xenon 129 Ventilation MRI in Cystic Fibrosis with Spiral Imaging and Flip-Angle Correction. Hussain, R; Plummer, JW; Bdaiwi, AS; Willmering, MM; Kramer, EL; Walkup, LL; Cleveland, ZI. Radiology: Cardiothoracic Imaging. 2025; 7:e240574.

TGF-β induces excessive pulmonary IL-6 secretion in cystic fibrosis via PI3K. Scharf, G; Davidson, CR; Ustiyan, V; Falkenberg, LG; Adavalli, A; Meeker, JD; Morgan, H; Ostmann, AJ; Hudock, KM; Brewington, JJ; Clancy, JP; Kramer, EL. American Journal of Physiology: Lung Cellular and Molecular Physiology. 2025; 329:L470-L479.

732 A genetic algorithm-derived single index model for integrating environmental risk into longitudinal lung function prediction in cystic fibrosis. Gecili, E; Szczesniak, R; Kramer, E. Journal of Cystic Fibrosis. 2025; 24:s437b-ss438.

Longitudinal Monitoring of Lumacaftor/Ivacaftor Response in Young Children with Cystic Fibrosis Lung Disease Using 129Xe MRI. Bdaiwi, AS; Roach, DJ; West, ME; Willmering, MM; Daou, AW; Hossain, MM; Kramer, EL; Amin, R; Walkup, LL; Cleveland, ZI; Woods, JC. Academic Radiology. 2025; 32:6238-6249.

The impact of highly effective modulator therapy on sinusitis and dysosmia in young children with cystic fibrosis: a prospective study protocol. Liu, CM; Fischer, JL; Zemanick, ET; Woods, JC; Markarian, KK; Fain, SB; Froh, D; Heltshe, SL; Hoffman, LR; Humphries, SM; Trout, AT; Goss, CH; Taylor-Cousar, JL; Beswick, DM. ERJ Open Research. 2025; 11:137-2024.

Robust identification of environmental exposures and community characteristics predictive of rapid lung disease progression. Peterson, CJ; Rao, MB; Palipana, A; Manning, ER; Vancil, A; Ryan, P; Brokamp, C; Kramer, E; Szczesniak, RD; Gecili, E. Science of the Total Environment. 2024; 950:175348.

198 Neutrophil extracellular traps increase Pseudomonal density in human bronchial epithelia. Dasgupta, A; Imbrogno, M; Collins, M; Merlin, L; Kramer, E; Brewington, J; Morgan, H; Meeker, J; Mahajan, S; Wozniak, D; Gardner, J; Trapnell, B; Clancy, J; Hudock, K. Journal of Cystic Fibrosis. 2024; 23:s110.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Loading ...
Loading ...